Ferroptosis-IN-13
Ferroptosis-IN-13 (compound NY-26) is a ferroptosis inhibitor. Ferroptosis-IN-13 inhibits RSL3 -induced ferroptosis in 786-O cells with an EC50 value of 62 nM[1].
Product Specifications
UNSPSC
12352005
Target
Ferroptosis
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
FC1=C(F)C=C(COC2=C(C3N(C4=CC=CC=C4)N=C(C(C)=O)N3C5=CC=C(N(C)C)C=C5)C=CC=C2OC)C=C1
Molecular Formula
C32H30F2N4O3
Molecular Weight
556.60
References & Citations
[1]Jiawei Zhang, et al. Discovery and optimization of 1,2,4-triazole derivatives as novel ferroptosis inhibitors. Eur J Med Chem. 2025 Feb 15:284:117192.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB2416-100 1x 100 µL
CD5 (Mantle Cell Lymphoma Marker) (CD5/2416), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LY424650 100 µg
TSH beta (TSHB) (NM_000549) Human Over-expression Lysate
Sign In for Pricing
View Details 
